We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.

Skip to main content

The Jackson Laboratory

Home

Recent Searches

Share this Post

Share on facebook
Share on twitter
Share on linkedin
Share on email

Home
Conference Posters and Presentations
PEGS Europe 2026: A Humanized FcRn x Albumin Model to Assess HAS-Fused Therapeutic Candidates and FcRn Antagonists

PEGS Europe 2026: A Humanized FcRn x Albumin Model to Assess HAS-Fused Therapeutic Candidates and FcRn Antagonists

Published Date November 4, 2026

No Previous Flipbooks
Next Flipbook

PEGS Europe 2026: A comparison of preclinical models for PK allometric scaling of antibodies

Most Recent Flipbooks

about 14 hours ago
PEGS Europe 2026: A comparison of preclinical models for PK allometric scaling of antibodies

Read More
3 months ago
Comparative Metabolic Profiling of Semaglutide, Tirzepatide and Retatrutide in db/db mice

Read More
3 months ago
High-Throughput Genome Editing and Quality Control of Human iPSC Lines for Large Scale Disease Modeling

Read More
3 months ago
Automated iPSC-derived Islet Organoids Platform for Population-scale Modeling of Type 2 Diabetes

Read More
3 months ago
A Scalable and Reversible Strategy to Knock Out Gene Function in Human Induced Pluripotent Stem Cells

Read More
3 months ago
Development Approach to Modeling Intracranial Germ Cell Tumors Using Human Pluripotent Stem Cells

Read More
3 months ago
Natural Genetic Variation Reveals Loci Controling Differentiation Propensity and Lineage Specification in Mouse Embryonic Stem Cells

Read More
3 months ago
Diverse Embryonic Stem Cells Reveal Coevolved Genome Regulatory Incompatibilities Affecting Viability and Fertility

Read More
3 months ago
Mapping RPE-to-Photoreceptor Programming for Stem Cell Therapy

Read More
3 months ago
High-Throughput Expansion and Banking of iPSC Lines Using the JAX-NYSCF Automated Platform

Read More
3 months ago
Diet-induced Obese Tg32 (hFcRN) : a New Platform for PK Analysis of Anti-obesity Peptide-Fc Based and Antibody Therapeutics

Read More
3 months ago
A Third-Generation Immune Humanized Mouse Model for the Study of Novel Immuno-Oncology Approaches

Read More
3 months ago
NSGF6T, A Humanized Mouse Model Recapitulating Key Features of Psoriasis for Translational Research

Read More
3 months ago
A New and Differentiated Transgenic Platform for Rapid Generation of Developable Human Therapeutic Antibodies

Read More
3 months ago
Novel Mouse Models for Cancer Research

Read More
3 months ago
The novel CD34 huNSG-FLT3-IL15 mouse strain with enhanced development of human T-, myeloid, dendritic, and natural killer cells is a new...

Read More
3 months ago
Characterization of a New FcRn Humanized Model to Evaluate the PK of Life-Extended Antibody Drug Candidates_Poster

Read More
11 months ago
Long-duration digital home cage phenotyping greatly enhances reproducibility of behavioral studies

Read More
11 months ago
Applying Digital measures to assess dose-dependent effects of a neuroactive compound in mice

Read More
11 months ago
Xeno-free, efficient derivation of ipsc-derived microglia for neuroimmunology research

Read More

Recommended for you

Return to Home

© The Jackson Laboratory